Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization-MedSci.cn

Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization

Liu, Y; Shi, MT; Chen, SG; Wan, WQ; Shen, LJ; Shen, BY; Qi, H; Cao, F; Wu, Y; Huang, T; Chen, GJ; Mo, JQ; Ye, DD; Zhang, YQ; Feng, ZQ; Fan, WJ

Fan, WJ (corresponding author), Sun Yat Sen Univ Canc Ctr, Dept Minimally Invas Intervent Therapy, Guangzhou 510060, Peoples R China.; Fan, WJ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.

Abstract

Context and Aims: The identification of inflammation-related prognostic heterogeneity in intermediate-stage hepatocellular carcinoma (HCC) can reveal ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization

科室

工具

服务